ATP synthase inhibition of Mycobacterium avium is not bactericidal

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 11, 2009, Pages 4927-4929

  Lounis, Nacer ^a   Gevers, Tom ^a   Van Den Berg, Joke ^a   Vranckx, Luc ^a   Andries, Koen ^a  

^a Johnson and Johnson ^*  (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

1 (6 BROMO 2 METHOXY 3 QUINOLINYL) 4 DIMETHYLAMINO 2 (1 NAPHTHYL) 1 PHENYL 2 BUTANOL; AMIKACIN; CLARITHROMYCIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; ATYPICAL MYCOBACTERIOSIS; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; CONTROLLED STUDY; DRUG EFFICACY; ENZYME INHIBITION; FEMALE; MAXIMUM PLASMA CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; MOUSE; MYCOBACTERIUM AVIUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTITUBERCULAR AGENTS; ENZYME INHIBITORS; FEMALE; MICE; MICE, INBRED C57BL; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM AVIUM; QUINOLINES;

EID: 70350267045     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00689-09     Document Type: Article

References (16)

1. Andries, K., P. Verhasselt, J. Guillemont, H. W. H. Göhlmann, J. M. Neefs, H. Wrinkler, J. V. Gestel, P. Timmerman, M. Zhu, E. Lee, P. Williams, D. de Chaffoy, H. Huitric, S. Hoffner, E. Cambau, C. Truffot-Pernot, N. Lounis, and V. Jarlier. 2005. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science 307:223-227.
2. Benson, C. A., P. L. Williams, J. S. Currier, F. Holland, L. F. Mahon, R. R. MacGregor, C. B. Interlied, C. Flexner, J. Neidig, R. Chaisson, G. F. Notario, R. Hafner, and the AIDS Clinical Trials Group 223 Protocol Team. 2003. A prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons with acquired immunodeficiency syndrome. Clin. Infect. Dis. 37:1234-1243.
3. Diacon, A. H., A. Pym, M. Grobusch, M. Patientia, R. Rustomjee, L. Page- Shipp, C. Pistorius, R. Krause, M. Bogoshi, G. Churyard, A. Venter, J. Allen, J. C. Palomino, T. De Marez, R. P. G. van Heeswijk, N. Lounis, P. Meyvisch, J. Verbeeck, W. Parys, K. De Beule, K. Andries, and D. F. McNeeley. The investigational diarylquinoline TMC207 for multidrug-resistant TB. N. Engl. J. Med. 360:2397-2405.
4. Fernandes, P. B., D. J. Hardy, D. McDaniel, C. W. Hanson, and R. N. Swanson. 1989. In vitro and in vivo activities of clarithromycin against Mycobacterium avium. Antimicrob. Agents Chemother. 33:1531-1534.
5. Gangadharam, P. R. J., V. K. Perumal, N. R. Podapati, L. Kesavalu, and M. D. Iseman. 1988. In vivo activity of amikacin alone or in combination with clofazimine or rifabutin or both against experimental Mycobacterium avium complex infections in beige mice. Antimicrob. Agents Chemother. 32:1400-1403.
6. Griffith, D. E., B. A. Brown-Elliott, S. Shepherd, J. McLarty, L. Griffith, and R. J. Wallace, Jr. 2005. Ethambutol ocular toxicity in treatment regimens for Mycobacterium avium complex lung disease. Am. J. Respir. Crit. Care Med. 172:250-253.
7. Huang, J. H., P. N. Kao, V. Adi, and S. J. Ruoss. 1999. Mycobacterium avium-intracellulare pulmonary infection in HIV-negative patients without preexisting lung disease: diagnostic and management limitations. Chest 115:1033-1040.
8. Huitric, E., P. Verhasselt, K. Andries, and S. E. Hoffner. 2007. In vitro antimycobacterial spectrum of a diarylquinoline ATP synthase inhibitor. Antimicrob. Agents Chemother. 51:4202-4204.
9. Inderlied, C. B., P. T. Kolonski, M. Wu, and L. S. Young. 1989. Amikacin, ciprofloxacin, and imipenem treatment for disseminated Mycobacterium avium complex infection of beige mice. Antimicrob. Agents Chemother. 33:176-180.
10. Iseman, M. D. 2002. Medical management of pulmonary disease caused by Mycobacterium avium complex. Clin. Chest Med. 23:633-641.
11. Ji, B., N. Lounis, C. Truffot-Pernot, and J. Grosset. 1994. Effectiveness of various antimicrobial agents against Mycobacterium avium complex in the beige mouse model. Antimicrob. Agents Chemother. 38:2521-2529.
12. Lounis, N., B. Ji, C. Truffot-Pernot, and J. Grosset. 1995. Selection of clarithromycin-resistant Mycobacterium avium complex during combined therapy using the beige mouse model. Antimicrob. Agents Chemother. 39:608-612.
13. Lounis, N., N. Veziris, A. Chauffour, C. Truffot-Pernot, K. Andries, and V. Jarlier. 2006. Combinations of R207910 with drugs used to treat multidrug-resistant tuberculosis have the potential to shorten treatment duration. Antimicrob. Agents Chemother. 50:3543-3547.
14. Mouton, J. W., M. N. Dudley, O. Cars, H. Derendorf, and G. L. Drusano. 2005. Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update. J. Antimicrob. Chemother. 55:601-607.
15. Rozenweig, D. Y. 1979. Pulmonary mycobacterial infections due to Mycobacterium intracellulare avium complex: clinical features and course in 100 consecutive cases. Chest 75:115-119.
16. Struillou, L., Y. Cohen, N. Lounis, G. Bertrand, J. Grosset, J.-L. Vildé, J.-J. Pocidalo, and C. Perronne. 1995. Activities of roxithromycin against Mycobacterium avium infections in human macrophages and C57BL/6 mice. Antimicrob. Agents Chemother. 39:878-881.